Clinical Scorecard: USB-powered warm compresses improve tear stability

At a Glance

Key Highlights

• In a randomized crossover trial of 15 adults, both treatments were used for 10 minutes daily over 5 days, with a 2-week washout before crossover.
• Mean tear breakup time increased from 7.2 to 9.5 seconds with the USB-powered compress and from 7.3 to 7.9 seconds with the disposable mask; the Day 5 between-device difference was statistically significant.
• Mean tear meniscus height increased from 0.16 to 0.28 mm with the USB-powered compress and from 0.16 to 0.22 mm with the disposable mask; the between-device difference was statistically significant.
• SPEED symptom scores improved modestly with both devices, with no statistically significant between-device difference.
• Visual acuity remained stable and no adverse events were reported during the short, supervised trial.

Guideline-Based Recommendations

Diagnosis

• Trial eligibility required an Ocular Surface Disease Index score of at least 13 and noninvasive tear breakup time of 10 seconds or less in at least one eye.

Management

• The study compared a USB-powered warm compress with a disposable self-heating mask, each used for 10 minutes daily for 5 consecutive days; it does not establish a general treatment recommendation.

Monitoring & Follow-up

• The primary outcome was noninvasive tear breakup time measured with the OCULUS Keratograph 4M.
• Secondary outcomes included tear meniscus height, visual acuity, and SPEED questionnaire scores.

Risks

• No adverse events were reported during the intervention phases.
• Long-term effectiveness and whether changes in tear measurements translate into lasting, meaningful symptom benefits remain uncertain.

Patient & Prescribing Data

Participants received each device for 10 minutes daily over 5 days under supervision. Qualitative feedback indicated a preference for the USB-powered device because of consistent warmth and ease of reactivation; at-home adherence was not assessed.

Clinical Best Practices

• Interpret the findings in light of the small sample, single-center design, short treatment periods, and young study population.
• The investigators did not measure eyelid surface temperatures or assess meibography and other structural or biochemical changes.
• The trial was registered after recruitment began, and enrollment of 15 participants was below the originally planned recruitment of up to 50.
• The article reports that the corresponding author confirmed Table 1 values after reviewing raw data because the published abstract reported different Day 5 measurements.

Related Resources & Content

• PLOS One trial (complete citation and URL needed)